Investigating the link between cocaine use and stroke risk in people living with HIV
Cocaine use, viral suppression and precursors of stroke in HIV infection
This study is looking at how using cocaine and other drugs might increase the chances of having a stroke for people living with HIV, and it aims to help doctors better understand and prevent these risks for their patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10820501 on NIH RePORTER |
What this research studies
This research focuses on understanding how cocaine and other drug use may affect the risk of stroke in individuals living with HIV. By examining the relationship between drug use, inflammation, and stroke mechanisms, the study aims to improve stroke risk assessments for patients who use drugs. Participants will be recruited from HIV clinics and community settings, ensuring a diverse representation of individuals affected by these issues. The findings could lead to better prevention strategies and treatment options for those at risk.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also use cocaine or other drugs.
Not a fit: Patients who do not use cocaine or other drugs and are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved stroke risk assessments and prevention strategies for people living with HIV who use cocaine and other drugs.
How similar studies have performed: While there is limited research specifically addressing cocaine use and stroke risk in HIV patients, studies have shown that substance use significantly impacts health outcomes, suggesting potential for meaningful insights from this research.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Riley, Elise D. — University of California, San Francisco
- Study coordinator: Riley, Elise D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.